Can cerebral infarction be cured? What is the best medicine for cerebral infarction?

Can cerebral infarction be cured? What is the best medicine for cerebral infarction?

Cerebral infarction (cerebral infarction, cerebral infarction, dilated stroke), also known as brain “disease”, resulting in decreased cerebral blood flow, insufficient blood supply to the brain, cerebral edema, brain tissue size, hypoxia, compression, necrosisIt is easy to leave different degrees of sequelae, which seriously affects the health of the patients and family happiness.

Can cerebral infarction be cured?

What is the best medicine for cerebral infarction?

Can cerebral infarction be cured?

Cerebral infarction is a chronic disease with acute onset, which will seriously affect the brain function of the patient. Over time, the patient will have a progressive decline, and finally lead to cerebral vascular dementia. In severe cases, the plant survival state, the clinical common eye is skewed, and the speech is unclear.Limb numbness, bedridden, half-length, drooling, aphasia, dementia, drinking water, difficulty swallowing, incontinence and other symptoms.

Once the disease is infected, it will not heal for a long time, bringing long-term pain and penetration to the society and the family.

After an episode of cerebral infarction, if you go to the hospital for treatment in time, the risk will be greatly reduced.

Because the brain neurons of the cerebral infarction syndrome cause great damage, even if the patient with cerebral infarction is not life-threatening, the patient may have symptoms such as headache, hemiplegia, dysphagia, unclear speech, nausea, vomiting, etc.In a variety of situations, severe cases are quickly unconscious.

Therefore, scientific and timely treatment is very important.

What is the best medicine for cerebral infarction?

The first category is vasodilators.

In the past, as long as the drug can make the cerebral blood vessels dilate, it can make the blood flow more from the involved blood vessels.

At first, it was discovered that dilatation of vasospasm could not do this, and it would cause blood at the site to flow back into healthy brain tissue (this is called the brain steal syndrome), so it is not specified.
The second category is drugs that improve microcirculation and expand blood volume.

At present, such drugs are not treated, but patients with cardiovascular disease should be used with caution, otherwise it may cause heart failure.

The third category is drugs that dissolve thrombus.

It is most desirable to use such drugs for the purpose of dissolving emboli, but large doses are often required for systemic intravenous administration, sometimes causing bleeding.

Interventional therapy is recommended for multi-directional disease, which is to directly inject the drug into the infarct through the catheter to dissolve the embolus. However, a cerebral angiography should be performed before and after the treatment, which itself has certain risks, not to mention the danger.Interventional therapy requires patients to be performed within 6 hours of getting sick, sometimes with missed opportunities.

The fourth category is anticoagulant therapy.

A variety of drugs can prevent blood clotting, but the time and activity of prothrombin should be checked every day, and hospitals with poor conditions cannot.

In addition, anticoagulant therapy also has the risk of bleeding.

The fifth category is the use of calcium ion antagonists.

These drugs can prevent calcium ions from being injected into the cells from outside the cells, slightly dilate the cerebral blood vessels, protect brain cells, and increase the utilization of oxygen and glucose by brain cells.

The sixth category is a drug that prevents platelet aggregation.

The aggregation of platelets is often the beginning of cerebral thrombosis. If it can effectively block the aggregation of platelets, it may prevent further formation of blood collateral.

At present, such drugs are widely used in the world, but at the same time, it is more suitable as a preventive drug as a therapeutic drug, because the use of various drugs in the acute phase of stroke is not satisfactory.